Explore Sandbox crypto analysis with key momentum indicators and breakout levels of SAND/USDT to understand potential trend ...

Explore stablecoin development analysis with a focus on SDEV's 20.8% drop and market momentum signals revealing key trading ...

Azitra, Inc. announced the completion of Cohort 1 in its Phase 1/2 clinical trial evaluating ATR04-484 as a potential treatment for EGFR inhibitor (EGFRi)-associated skin rash. Following its review of ...

Investment company Flerie's portfolio company Atrogi reports positive results from an eight-week study of the drug candidate ATR-258 in 13 people who were overweight or had obesity. The treatment was ...

Flerie AB's (publ) portfolio company Atrogi has reported positive results from a clinical proof-of-mechanism study of its lead candidate ATR-258, a first-in-class, once-daily oral therapy designed to ...

Arista Stock: The AI stock leader is approaching a new buy point despite Monday's market weakness. Its RS line hit a new high ...

Introduction: Does this scenario sound familiar? When looking at charts on shorter timeframes, it is difficult to judge the ...

Peter Brandt says XRP’s charts alone provide reason to consider a trade as a potential inverse head-and-shoulders pattern forms near the $1.50-$1.55 neckline.

Bitcoin's weekly candles now sit above a stack of moving averages, and the upper edge of that band near $78K is where this ...

HBAR is pinned directly beneath the $0.10 resistance ceiling with smart money stacked aggressively long and taker order flow ...

Peter Brandt's XRP chart points to $5.40 long-term. See his price prediction, key levels, and why no target date was given.